Contacts

General enquiries: info@reneuron.com


Product and licensing enquires: licensing@reneuron.com


Press enquiries: Michael Hunt, Chief Executive Officer - ReNeuron


John Sinden, Chief Scientific Officer - ReNeuron: +44 (0)1483 302560


Lisa Baderoon, Mark Court, Isabel Podda - Buchanan Communications: +44 (0) 20 7466 5000


Please note that ReNeuron receives a large number of enquiries from interested parties regarding its technologies, therapeutic programmes and business operations.  Whilst the Company will try to answer as many queries as it can, it has limited resources with which to do so and unfortunately may not be able to respond in all cases. 


Please refer to the appropriate sections of the website for further information on the various aspects of ReNeuron's operations.




 



 


 



Top of pageTop of page

ReNeuron Group plc Head Office and Laboratories

10 Nugent Rd
Surrey Research Park
Guildford, Surrey
GU2 7AF
UK

Telephone: +44 (0)1483 302560
Fax: +44 (0)1483 534864

ReNeuron regrets that it cannot advise or deal directly with individual patients or their physicians, relatives or friends concerning those patients' medical conditions and the suitability of ReNeuron's prospective stem cell therapies for treating them.


Further information regarding the the Phase I clinical trial of ReNeuron's ReN001 stem cell therapy for disabled stroke patients may be found on the clinicaltrials.gov registry: click here